ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : Systemic autoimmunity
Field of Research : Medical Virology
Clear All
Filter by Field of Research
Medical Virology (3)
Autoimmunity (1)
Cellular Immunology (1)
Immunology (1)
Medical Bacteriology (1)
Tumour Immunology (1)
Filter by Socio-Economic Objective
Blood Disorders (1)
Cancer and Related Disorders (1)
Diabetes (1)
Immune System and Allergy (1)
Infectious Diseases (1)
Filter by Funding Provider
National Health and Medical Research Council (2)
Australian Research Council (1)
Filter by Status
Closed (3)
Filter by Scheme
Project Grants (2)
Linkage Infrastructure, Equipment and Facilities (1)
Filter by Country
Australia (1)
Filter by Australian State/Territory
VIC (1)
  • Researchers (3)
  • Funded Activities (3)
  • Organisations (6)
  • Funded Activity

    Understanding The Role Of Host Arih2 In Defence Against Viral Infection And Disease Pathogenesis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $537,737.00
    Summary
    A set of proteins, called E3 ligases, modulate many aspects of immunity. Arih 2 is a novel E3 ligase that limits immune cell activation to maintain the immune system in a quiescent state. The details of how Arih2 functions and its role in immunity to chronic overwhelming infection are the focus of this study. The insights gained from these studies have important implications for our understanding of how immune responses can be promoted during infection or halted in autoimmunity.
    More information
    Funded Activity

    Elucidating The Pathogenic Role Of Rotavirus Infection In Type 1 Diabetes Development

    Funder
    National Health and Medical Research Council
    Funding Amount
    $535,579.00
    Summary
    Rotavirus infection is the main cause of severe diarrhoea in children, and has been implicated in accelerated progression of genetically at-risk children towards type 1 diabetes in two independent studies. My group has further discovered that rotavirus also accelerates diabetes onset in mice in a novel immunological process. In this project, we will determine the mechanism behind this disease exacerbation in the mice, to facilitate understanding of the process in children.
    More information
    Funded Activity

    Linkage Infrastructure, Equipment And Facilities - Grant ID: LE110100106

    Funder
    Australian Research Council
    Funding Amount
    $350,000.00
    Summary
    An advanced flow cytometry facility for the Peter Doherty Institute. The establishment of a flow cytometry facility in the new Peter Doherty Institute for Infection and Immunity will enhance capacity to investigate immunity to a broad range of very serious diseases. This project will support researchers studying viral and bacterial infection as well as cancer and autoimmunity.
    More information

    Showing 1-3 of 3 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback